ADVERTISING FEATURE l


Easy to Read Screen “The nurses told us they need to be able to take in the information easily, not struggle to see the key criteria on a screen filled with irrelevant data. So we designed the BD neXus screen so that it shows only critical information including drug name, the rate and the limit, in a font large enough to see from a distance.”


l


Colour Coding Richard also explained how they introduced a new simple colour coding system on the touch screen. “It provides key information about the infusion pump and the mode that it’s running in two colours: blue background for ml/hr and an orange background for Guardrails™. So, at a glance across a busy ward, you’re able to see which pumps are running in the protective protocol.”


l


Simplified Hand-Over “In the ICU, patients may require multiple infusions, so we have improved inter-pump communication and the handover mode to help minimise interruptions in delivery of critical drugs. When one pump is coming to the end of its infusion, it’s communicating to a second pump that is ready to automatically start, as the first pump finishes, maintaining a continuous infusion. A huge improvement compared to manual syringe changes.”


BD AlarisTM TM l Connectivity Improving workflow efficiency . BD AlarisTM


BD neXus Medication Safeware facilitates auto-documentation of infusion data in Electronic Medical Records (EMR) and Patient Data Management Systems (PDMS). It utilises Health Level 7 (HL7®) messaging and is conforming with the Integrating the Healthcare Enterprise (IHE™) PCD-01 and PCD- 10 transaction profiles, ensuring seamless integration and interoperability with existing healthcare systems.


neXus PK offers a user-friendly interface and a large display showing all critical infusion data at a glance.


Promoting patient safety During complex OR procedures, patient safety is a concern. The BD AlarisTM


neXus PK Syringe Pump


Richard Bailey, Technical Marketing Associate Director, BD


Timely, precise and effective anaesthesia Managing your patients’ anaesthesia requires precise devices


1


Workflow efficiency is highly important in busy operating rooms (OR)2


platform, the BD Alaris neXus PK syringe pump is designed to offer timely, precise and effective anaesthesia for children and adults.


References 1. Daleen Penoyer KG, Aurea Middleton. Comparison of safety and usability between peristaltic and pneumatic large-volume intravenous smart pumps during actual clinical use. BMJ Innov. 2022;8:78–86.


. Built on the BD Alaris TM neXus


2. Giuliano KK. IV Smart Pumps: The Impact of a Simplified User Interface on Clinical Use. Biomed Instrum Technol. 2015;Suppl:13-21.


3. Kerlin MP, McPeake J, Mikkelsen ME. Burnout and Joy in the Profession of Critical Care Medicine. Crit Care. 2020;24(1):98.


Increased medication safety for all population The BD AlarisTM


neXus PK syringe pump has


4. Husch M, Sullivan C, Rooney D, Barnard C, Fotis M, Clarke J, Noskin G. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology. Qual Saf Health Care. 2005;14(2):80-6.


neXus PK offers a broad range of plasma (PK) and


Moreover, the solution can integrate with Alarm Monitoring solutions using IHE™ conformant PCD-04 transactions. This feature facilitates near-real-time monitoring of pump alarms in Alarm Monitoring solutions, helping to enhance patient safety and care.


. Wi-Fi enabled


The BD neXus platform has been designed with a high focus on security, ensuring the utmost protection of your personal data with robust encryption mechanisms to safeguard personal data both in storage and during transit.


Wireless transfer of infusion data through the AlarisTM Communication Engine to the hospital information systems. Automatic wireless download of pump event logs and the update of datasets from anywhere in the hospital improves the process without interrupting clinical workflows as pumps are infusing.


Richard concluded, “The ultimate role in product development is to distil functionality down to what really matters. Starting with the right device design can ensure that nurses can easily, quickly and intuitively use infusion pumps, helping to minimise the risk of errors and making it simple to perform complex tasks correctly, time after time.”


1030 Eskdale Road, Winnersh Triangle, Wokingham, RG41 5TS


effect site (PD) targeting models. The Eleveld Propofol and Eleveld Remifentanil models are the only TCI models able to provide PD target steering for children. They help anaesthetists meet IV anaesthesia requirements in a safe, timely and accurate way3


5. Ann Blandford AC, Anna Cox, Andy Gimblett, Paolo Masci, Gerrit Niezen, Patrick, Oladimeji HT, Chris Vincent, Sarah Wiseman. CHI MED Guidelines for number entry interface design (infusion devices). https://wp1.cs.ucl.ac.uk/chi-med/wp-content/ uploads/sites/12/2020/07/CHIMED-number-entry-design-guidance-1.pdf; 2013.


patent pending medication safety to minimise the potential for programming errors, especially when setting up infusions for children. This technology automatically adjusts the suggested default settings for height and weight based on the patient’s age that is entered when using the Eleveld propofol and Eleveld remifentanil TCI model. .


New TCI drug models* • Dexmedetomidine (Hannivoort-Colin) • Propofol (Eleveld), • Remifentanil (Eleveld), • Remifentanil (Kim-Obara-Egan) * refer to specifications for full list of drug models.


Let’s have a conversation


References 1 The_Safety_of_Target_Controlled_Infusions. Schnider (v0.1) TW, Minto CF, Struys MM, Absalom AR. The Safety of Target- Controlled Infusions. Anesth Analg. 2016 Jan;122(1):79-85. doi: 10.1213/ANE.0000000000001005. PMID: 26516801. 2 The Joint Commission International Standards. 7th Edition: January 2021. 3 Vandemoortele O, Hannivoort LN, Vanhoorebeeck F, Struys MMRF, Vereecke HEM. General Purpose Pharmacokinetic-Pharmacodynamic Models for Target-Controlled Infusion of Anaesthetic Drugs: A Narrative Review. J Clin Med. 2022 Apr 28;11(9):2487. doi: 10.3390/jcm11092487. PMID: 35566617; PMCID: PMC9101974.


MEDCAPTAIN MEDICAL TECHNOLOGY CO., LTD., 12th Floor, Baiwang Research Building, No.5158 Shahe West Road, Xili, Nanshan, 518055 Shenzhen, Guangdong, PEOPLE’S REPUBLIC OF CHINA


Becton, Dickinson U.K. Limited, 1030 Eskdale Road, Winnersh Triangle, Wokingham, RG41 5TS


bd.com/anaesthesia-uk BD, the BD Logo and Alaris are trademarks of Becton, Dickinson and Company. © 2022 BD. All rights reserved. (BD-91562, August 2023)


lp.bd.com/BD-neXus-UK


BD, the BD Logo and Guardrails are trademarks of Becton, Dickinson and Company or its affiliates. © 2024 BD. All rights reserved. BD-131917.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80